Skip to main content

McKesson Corporation company profile

  • MCK · NYSE
  • Distribution
  • Health Care Distributors
  • S&P 500
$1102.80+2.39%Close 13 Nov 2026 · Market value $127.9B

About McKesson Corporation

McKesson Corporation is a diversified healthcare services company that distributes pharmaceuticals, medical-surgical supplies, and related products and services to biopharma companies, care providers, pharmacies, manufacturers, and governments. Its operations are organized into four reportable segments: North American Pharmaceutical, which distributes branded, generic, specialty, biosimilar, and over-the-counter drugs in the United States and Canada; Oncology & Multispecialty, which supports oncology and specialty physician practices; Prescription Technology Solutions, which provides medication access and benefit technology services; and Medical-Surgical Solutions, which supplies non-acute and alternate-site healthcare providers in the U.S. The company also operates a network of Canadian pharmaceutical wholesale and retail businesses, and it has a national network of U.S. distribution centers.

A summary of the business section of the company's latest annual report, filed 8 May 2026.

Company facts

TickerMCK · NYSE
SectorDistribution
IndustryHealth Care Distributors
IndexS&P 500
Fiscal year ends31 March
Reporting currencyUSD
CIK927653
Latest annual report10-K, filed 8 May 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Brian S. TylerChief Executive Officer · Director28.0K · < 1%Sale under a 10b5-1 plan, 7 Jul 2026
Britt J. VitaloneEVP & CFO22.5K · < 1%Option exercise, 23 May 2026
LeAnn B. SmithEVP & Chief HR Officer6.6K · < 1%Sale under a 10b5-1 plan, 1 Jun 2026
Michele LauEVP and Chief Legal Officer3.4K · < 1%Sale under a 10b5-1 plan, 26 May 2026
Thomas L. RodgersEVP, Chief Strategy & BDO3.1K · < 1%Sale under a 10b5-1 plan, 2 Jun 2026
Dominic J. CarusoDirector650 · < 1%Grant or award, 22 Jul 2026
Bradley E. LermanDirector301 · < 1%Open-market sale, 10 Aug 2026
Maria N. MartinezDirector301 · < 1%Grant or award, 22 Jul 2026
Kathleen Wilson-ThompsonDirector301 · < 1%Grant or award, 22 Jul 2026
Rutledge Napoleon B JRSVP, Controller & CAO—Sale under a 10b5-1 plan, 8 Sep 2026
Fraga FranciscoEVP, CIO and CTO—Shares withheld for tax, 23 May 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

MCK in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.